Previous 10 | Next 10 |
2024-02-01 19:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-16 13:12:52 ET Summary RxSight reported preliminary Q4 results, capping off a record year for growth where sales climbed by approximately 82%. The company is capturing strong demand for its adjustable intraocular lens technology for cataract and lens replacement surgery. ...
2024-01-16 07:00:00 ET Summary Small cap stocks surged in the final two months of the year as the 10-year yield reversed direction. The Fed's actions in 2024 will determine the prospects for small cap stocks, with a rate cut in March improving their prospects. Small caps may f...
2024-01-08 11:16:56 ET More on RxSight RxSight, Inc. (RXST) Q3 2023 Earnings Call Transcript RxSight: Losing Altitude Despite 'Best Of Breed' Platform BTIG makes top medtech stock picks for 2024, sees sector stabilizing Seeking Alpha’s Quant Rating on ...
2024-01-08 08:31:52 ET Summary The healthcare sector was flat in 2023 year as a result of some unique issues. Drug price regulation will be a serious challenge for the sector this year. Defensive healthcare industry groups should do well during the first half and biotechnology...
2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...
ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth q...
2023-12-25 05:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-17 17:48:14 ET More on Abbott Laboratories, Glaukos, etc. Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio Zimmer Biomet: Still Many Questions After A Solid Year So Far Abbott Laboratories: One Of The Safest Dividend Growth Stocks O...
2023-11-12 04:19:02 ET RxSight, Inc. (RXST) Q3 2023 Earnings Conference Call November 09, 2023, 04:30 PM ET Company Participants Alex Huang - Director, Investor Relations Ron Kurtz - President and Chief Executive Officer Shelley Thunen - Chief Financial Officer ...
News, Short Squeeze, Breakout and More Instantly...
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second...
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. ...
Shareholders approved all agenda items and proposals of the Board of Directors Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of th...